Zoladex 3,6 mg implantat
Name | Zoladex 3,6 mg implantat |
---|---|
Marketing Authorisation Number | HR-H-247320153 |
Active Substance | goserelinacetat |
Composition | implantat u napunjenoj štrcaljki sadrži 3,6 mg goserelina u obliku goserelinacetata dispergiranog u biološki razgradivom matriksu kopolimera |
Pharmaceutical Form | implantat |
Manufacturer | AstraZeneca AB, Sodertalje, Švedska |
Marketing Authorisation Holder | AstraZeneca d.o.o., Ulica Vjekoslava Heinzela 70, Zagreb, Hrvatska |
Marketing Authorisation Date | 27.11.2015 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/14-02/265 |
Registration Number | 381-12-01/30-15-15 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L02AE03 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |